No abstract available
MeSH terms
-
Bisphosphonate-Associated Osteonecrosis of the Jaw* / drug therapy
-
Bone Density Conservation Agents*
-
Denosumab / adverse effects
-
Diphosphonates
-
Humans
-
Osteonecrosis* / chemically induced
-
Osteonecrosis* / drug therapy
-
Teriparatide / adverse effects
Substances
-
Teriparatide
-
Denosumab
-
Bone Density Conservation Agents
-
Diphosphonates